New York Senate Bill 488: Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

New York · 2025-2026 session

Status: In committee

What it does

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Latest action

referred to consumer affairs and protection (2026-05-12)

See how S 488 affects you on CapitolKey

Browse more bills · CapitolKey home